Company News
Current news about VEZOTIL drug, achievements of VETSTEM LLC and development of veterinary pharmaceuticals
Important News
Key events and company achievements
Important News! We're Reducing the Price of VEZOTIL® - Save Up to 13%
Starting May 1, 2026, VETSTEM LLC is reducing the price of VEZOTIL® for veterinary clinics from 3,100 to 2,700 rubles per bottle. The composition, quality, and established administration protocols remain unchanged.
Read more
VEZOTIL® Opens Access to the Professional VETRA App for Veterinary Anesthesiologists
VETSTEM LLC announces access to VETRA, an intelligent support system for veterinary anesthesiology with dosage calculation, clinical protocols, a drug database, patient monitoring, AI assistance, teamwork, and data export.
Read more
21st All-Russian VITAR Conference 2026
From April 22 to 23, 2026, Moscow will host the 21st All-Russian VITAR Conference with international AVA participation. VETSTEM LLC invites specialists to visit our booth to discuss VEZOTIL® — a Russian anesthetic based on tiletamine and zolazepam — and current topics in veterinary anesthesiology.
Read more
VEZOTIL®: New Design, New Bottles, and New Production Site
VETSTEM LLC announces an important milestone: updated packaging design and a new production site for VEZOTIL®. Starting May 2026, production will be carried out additionally at Stavropol Biopharma — one of the largest GMP-certified veterinary pharmaceutical enterprises in Russia. The changes reflect our commitment to increasing production volume and expanding supply geography.
Read moreAll News
Latest updates and company events
VEZOTIL® at the Moscow International Veterinary Congress MVC 2026
The 34th Moscow International Veterinary Congress (MVC 2026) will be held on April 8–10, 2026, at the Skolkovo Technopark. The congress will bring together more than 350 speakers and thousands of veterinary professionals. VETSTEM LLC — a resident of the Skolkovo Innovation Center and manufacturer of VEZOTIL® — will participate in the key veterinary event of the year.
Read more
Educational Seminar “Basic Anesthesia with VEZOTIL®” in Nizhny Novgorod
VETSTEM LLC held an educational seminar, “Basic Anesthesia,” in Nizhny Novgorod. The event speaker was Kamilla Arsatyan, veterinary anesthesiologist at the Biocontrol clinic and technical specialist for Vezotil. The program included a theoretical lecture and a practical master class with review of VEZOTIL® administration protocols in clinical practice, as well as analysis of challenging anesthesiology cases.
Read more
Growth of the Russian Veterinary Drug Market: VEZOTIL® Strengthens Its Position
According to RNC Pharma analysts, the Russian retail veterinary drug market reached RUB 49.1 billion in 2025, increasing by 17.6%. The share of domestic manufacturers rose to 56% by value and 74% by volume. Amid import substitution efforts, VEZOTIL® by VETSTEM LLC is strengthening its position as a Russian alternative to foreign anesthetics.
Read more
Webinar Series by Leading Russian Anesthesiologists Available for Viewing
The website vezotil.ru has published a webinar series on veterinary anesthesiology featuring leading veterinary physicians in Russia. Experts including E.A. Kornyushenkov, D.V. Vdovina, S. Olenchuk, I.L. Alekseev and other prominent veterinarians share clinical experience with VEZOTIL® and highlight the product’s predictable effect, good tolerability, and convenient dosing.
Read more
VEZOTIL® for Chronic Pain Control: New Research Data
VetPharma published an article by veterinary anesthesiologist O.V. Zakirova on the use of VEZOTIL® for chronic orthopedic pain control in dogs and cats. The study of 64 animals demonstrated a significant reduction in pain manifestations: only 13% of patients in the VEZOTIL® group exceeded the pain threshold versus 89% in the control group.
Read more
Expansion of Production Capacity to Increase VEZOTIL Output
Due to growing demand for VEZOTIL, VETSTEM LLC invested in modernization of production lines and expansion of manufacturing capacity.
Read more
VETSTEM LLC Participates in the International Exhibition “VetPharm 2023”
The company presented the innovative VEZOTIL product at the largest veterinary pharmaceutical exhibition, attracting the attention of specialists from more than 20 countries.
Read more
VEZOTIL Received a Registration Certificate from Rosselkhoznadzor
VEZOTIL successfully passed all required clinical trials and received official registration for use in veterinary practice in the Russian Federation.
Read more
Multicenter Clinical Studies Confirmed High Efficacy of VEZOTIL
Large-scale clinical studies of VEZOTIL were completed in leading veterinary clinics in Russia, demonstrating excellent results across key efficacy and safety parameters.
Read more